Arinobu Yojiro, Mizuno Shin-ichi, Chong Yong, Shigematsu Hirokazu, Iino Tadafumi, Iwasaki Hiromi, Graf Thomas, Mayfield Robin, Chan Susan, Kastner Philippe, Akashi Koichi
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
Cell Stem Cell. 2007 Oct 11;1(4):416-27. doi: 10.1016/j.stem.2007.07.004.
A hierarchical hematopoietic development with myeloid versus lymphoid bifurcation has been proposed downstream of the multipotent progenitor (MPP) stage, based on prospective isolation of progenitors capable of generating only myeloerythroid cells (common myeloid progenitor, CMP) or only lymphocytes (common lymphoid progenitor, CLP). By utilizing GATA-1 and PU.1 transcription factor reporters, here we identified progenitor populations that are precursors for either CMPs or CLPs. Two independent populations expressing either GATA-1 or PU.1 resided within the CD34(+)Sca-1(+)c-Kit(+) MPP fraction. The GATA-1(+) MPP displayed potent myeloerythroid potential without giving rise to lymphocytes, whereas the PU.1(+) MPP showed granulocyte/monocyte/lymphoid-restricted progenitor activity without megakaryocyte/erythroid differentiation. Furthermore, GATA-1(+) and PU.1(+) MPPs possessed huge expansion potential and differentiated into the original CMPs and CLPs, respectively. Thus, the reciprocal activation of GATA-1 and PU.1 primarily organizes the hematopoietic lineage fate decision to form the earliest hematopoietic branchpoint that comprises isolatable myeloerythroid and myelolymphoid progenitor populations.
基于对仅能生成髓系红细胞的祖细胞(普通髓系祖细胞,CMP)或仅能生成淋巴细胞的祖细胞(普通淋巴祖细胞,CLP)的前瞻性分离,有人提出在多能祖细胞(MPP)阶段下游存在髓系与淋巴系分化的分层造血发育过程。通过利用GATA-1和PU.1转录因子报告基因,我们在此鉴定出了作为CMP或CLP前体的祖细胞群体。两个分别表达GATA-1或PU.1的独立群体存在于CD34(+)Sca-1(+)c-Kit(+) MPP组分中。GATA-1(+) MPP表现出强大的髓系红细胞生成潜能,不会产生淋巴细胞,而PU.1(+) MPP则显示出粒细胞/单核细胞/淋巴系受限的祖细胞活性,不会发生巨核细胞/红细胞分化。此外,GATA-1(+)和PU.1(+) MPP具有巨大的扩增潜能,并分别分化为原始的CMP和CLP。因此,GATA-1和PU.1的相互激活主要组织造血谱系命运决定,以形成最早的造血分支点,该分支点包含可分离的髓系红细胞和髓系淋巴细胞祖细胞群体。